A discussion of how leading health researchers analyze various kinds of health data to affect real-world outcomes – from hunting for new virus strains in remote areas of Africa, to using advanced machine learning to determine treatment efficacy and build predictive models.
Roger Magoulas is the research director at O’Reilly Media and chair of the Strata + Hadoop World conferences. Roger and his team build the analysis infrastructure and provide analytic services and insights on technology-adoption trends to business decision makers at O’Reilly and beyond. He and his team find what excites key innovators and use those insights to gather and analyze faint signals from various sources to make sense of what others may adopt and why.
Jacomo Corbo is the chief scientist for QuantumBlack, a visual analytics firm that helps clients meet the analysis challenges of big data to make better decisions. Corbo is also the Canada Research Chair in Information and Performance Management at the University of Ottawa, and a Wharton Clayright Scholar at the University of Pennsylvania’s Wharton School of Business. His research has been funded by grants from the National Research Council, the Alfred P. Sloan Foundation, the Wharton Mack Center for Technological Innovation, the Wharton Customer Analytics Initiative, as well as by companies such as GE Finance and IBM.
Between January 2006 and June 2008, Corbo served as race strategist and subsequently as chief race strategist for the Renault F1 Team Ltd.
Corbo holds a Ph.D. from the Department of Computer Science at Harvard University, an S.M. in Applied Mathematics from the Harvard Graduate School of Engineering and Applied Sciences, and a B.Eng. in Electrical Engineering from McGill University.
Colin is a frequent speaker at international scientific and industry conferences and has appeared in numerous publications and television segments including The Wall Street Journal, CNBC Morning Call, Nature, Forbes, Wired, and The Economist. He serves as CEO and Chairman of GNS Healthcare’s parent company Via Science, and chairman of the board of Fina Technologies, a subsidiary of Via Science that applies next-generation artificial intelligence technology to real-time financial trading. He also serves on the board of directors of AesRx, a biopharmaceutical company dedicated to the development of a new treatment for sickle cell disease.
In 2004, Colin was named to MIT Technology Review’s TR100 list of the top innovators in the world under the age of 35. He graduated from Virginia Tech with a degree in physics and earned master’s degrees in physics from McGill University and Cornell University.
Dr. Nathan Wolfe is an epidemiologist who fights disease pandemics with an unprecedented early-warning system to forecast, pinpoint and control new plagues worldwide before they kill millions. He is the Lorry I. Lokey Visiting Professor in Human Biology at Stanford University and the Founder and CEO of Metabiota, as well as the Chairman of Global Viral. His survey of diseases that have historically had the greatest impact on humanity revealed that most started with animals. Based on this, he created a global network of sites in viral hotspots where people are highly exposed to animals and are most at risk for early infection when viruses leap from animals to humans.
Dr. Wolfe has received numerous awards including a Fulbright fellowship and an NIH Director’s Pioneer Award and was chosen as a National Geographic Emerging Explorer and World Economic Forum Young Global Leader. He was also named one of Time Magazine’s 100 Most Influential People in the World for 2011. Nathan has over 80 scientific publications and his work has been published in or covered by Nature, Science, The New York Times, The Economist, NPR, The New Yorker and Forbes among others. He has received support totaling over $30m in grants and contracts from Google.org, the National Institutes of Health, the National Science Foundation, the Bill & Melinda Gates Foundation and the US Department of Defense and others.
For information on exhibition and sponsorship opportunities at the conference, contact Sharon Pierce at (203) 304-9476 or email@example.com
For information on trade opportunities with O'Reilly conferences contact mediapartners
For media-related inquiries, contact Maureen Jennings at firstname.lastname@example.org
View a complete list of Strata Rx contacts